Search Results - "Munschauer, FE"

Interpreting patient/informant discrepancies of reported cognitive symptoms in MS by Carone, D A, Benedict, R H B, Munschauer, 3rd, F E, Fishman, I, Weinstock-Guttman, B

“…Although numerous studies have shown that brain-damaged patients tend to underestimate neuropsychological (NP) impairment when self-ratings are compared to…”
Get more information

Repeated assessment of neuropsychological deficits in multiple sclerosis using the Symbol Digit Modalities Test and the MS Neuropsychological Screening Questionnaire by Benedict, RHB, Duquin, JA, Jurgensen, S, Rudick, RA, Feitcher, J, Munschauer, FE, Panzara, MA, Weinstock-Guttman, B

“…Background Brief cognitive performance tests and self-report measures of neuropsychological symptoms have been proposed for screening purposes in multiple…”
Get full text

Psychometrics and normative data for the Multiple Sclerosis Functional Composite: replacing the PASAT with the Symbol Digit Modalities Test by Drake, AS, Weinstock-Guttman, B., Morrow, SA, Hojnacki, D., Munschauer, FE, Benedict, RHB

“…The MS Functional Composite (MSFC) is a continuous scale of neurological disability for patients with multiple sclerosis (MS). Cognition is represented by the…”
Get full text

Cost Analysis Of Patients With Multiple Sclerosis Newly Initiating Subcutaneous Interferon β-1a Versus Oral Disease-Modifying Drugs by Kozma, CM, Munschauer, FE, Phillips, AL

Get full text

PND59 - Cost Analysis Of Patients With Multiple Sclerosis Newly Initiating Subcutaneous Interferon β-1a Versus Oral Disease-Modifying Drugs by Kozma, CM, Munschauer, FE, Phillips, AL

Get full text

Subjective fatigue is not associated with cognitive impairment in multiple sclerosis: cross-sectional and longitudinal analysis by Morrow, SA, Weinstock-Guttman, B, Munschauer, FE, Hojnacki, D, Benedict, RHB

“…Background Studies in multiple sclerosis (MS) report conflicting conclusions regarding fatigue and cognition, which may partly be due to the use of small…”
Get full text

Gender-related differences in MS: a study of conventional and nonconventional MRI measures by Antulov, R, Weinstock-Guttman, B, Cox, JL, Hussein, S, Durfee, J, Caiola, C, Dwyer, MG, Bergsland, N, Abdelrahman, N, Stosic, M, Hojnacki, D, Munschauer, FE, Miletic, D, Zivadinov, R

“…Background Studies showed gender-associated differences in multiple sclerosis (MS) disease evolution and in the evolution of conventional magnetic resonance…”
Get full text

Neutralising antibodies to interferon beta during the treatment of multiple sclerosis by Giovannoni, G, Munschauer, F E, Deisenhammer, F

“…ANTIBODIES ELICITED BY INTERFERON BETA An immune response against protein based drugs is not unusual. 6 For example, neutralising antibodies have been reported…”
Get full text

A longitudinal study of brain atrophy in relapsing multiple sclerosis by SIMON, J. H, JACOBS, L. D, SIMONIAN, N, LAJAUNIE, M, MILLER, D. E, WENDE, K, MARTENS-DAVIDSON, A, KINKEL, R. P, MUNSCHAUER, F. E, BROWNSCHEIDLE, C. M, CAMPION, M. K, RUDICK, R. A, COOKFAIR, D. L, HERNDON, R. M, RICHERT, J. R, SALAZAR, A. M, FISCHER, J. S, GOODKIN, D. E

Get full text

Gender effects on intramuscular interferon beta-1a in relapsing–remitting multiple sclerosis: analysis of 1406 patients by Rudick, RA, Kappos, L, Kinkel, R, Clanet, M, Phillips, JT, Herndon, RM, Sandrock, AW, Munschauer, FE

“…Background: We aimed to evaluate effects of gender on efficacy and safety of intramuscular (IM) interferon beta (IFNβ)-1a in patients with relapsing–remitting…”
Get full text

Incidence and significance of neutralizing antibodies to interferon beta-1a in multiple sclerosis by RUDICK, R. A, SIMONIAN, N. A, MASS, M. K, RICHERT, J. R, SALAZAR, A. M, MUNSCHBAUER, F. E, COOKFAIR, D. L, SIMON, J. H, JACOBS, L. D, ALAM, J. A, CAMPION, M, SCARAMUCCI, J. O, JONES, W, COATS, M. E, GOODKIN, D. E, WEINSTOCK-GUTTMAN, B, HERNDON, R. M

Get full text

Whole-Brain Atrophy in Multiple Sclerosis Measured by Automated versus Semiautomated MR Imaging Segmentation by Sharma, Jitendra, Sanfilipo, Michael P, Benedict, Ralph H. B, Weinstock-Guttman, Bianca, Munschauer, Frederick E., III, Bakshi, Rohit

“…Semiautomated and automated methods are used to measure whole-brain atrophy in multiple sclerosis (MS), but their comparative reliability, sensitivity, and…”
Get full text

Thalamic Involvement in Multiple Sclerosis: A Diffusion-Weighted Magnetic Resonance Imaging Study by Fabiano, Andrew J., Sharma, Jitendra, Weinstock-Guttman, Bianca, Munschauer, Frederick E., Benedict, Ralph H. B., Zivadinov, Robert, Bakshi, Rohit

Get full text

Multiple sclerosis characteristics in African American patients in the New York State Multiple Sclerosis Consortium by WEINSTOCK-GUTTMAN, B, JACOBS, L. D, GOTTESMAN, M. H, HERBERT, J, HOLUB, R, LAVA, N. S, LENIHAN, M, LUSINS, J, MIHAI, C, MILLER, A. E, PEREL, A. B, SNYDER, D. H, BROWNSCHEIDLE, C. M, BAKSHI, R, GRANGER, C. V, GREENBERG, S. J, JUBELT, B, KRUPP, L, MUNSCHAUER, F. E, RUBIN, D, SCHWID, S, SMIROLDO, J, BAIER, M, REA, D. F, APATOFF, B. R, BLITZ, K. M, COYLE, P. K, FRONTERA, A. T, GOODMAN, A. D

“…The objective of this study was to determine the clinical characteristics of multiple sclerosis (MS) in African American (AA) patients in the New York State…”
Get full text

Eight-year immunogenicity and safety of interferon beta-1a-Avonex®treatment in patients with multiple sclerosis by Herndon, Robert M, Rudick, Richard A, Munschauer, Frederick E, Mass, Michele K, Salazar, Andres M, Coats, Michael E, Labutta, Robert, Richert, John R, Cohan, Stanley L, Genain, Claude, Goodkin, Donald, Toal, Martin, Riester, Katherine

“…An open-label extension study of the phase III trial of intramuscular interferon beta-1a (IFNβ-1a-Avonex) was conducted to evaluate the immunogenicity and…”
Get full text

Impact of interferon beta-1a on neurologic disability in relapsing multiple sclerosis by RUDICK, R. A, GOODKIN, D. E, ALAM, J. J, SIMONIAN, N. A, CAMPION, M. K, BARTOSZAK, D. M, BOURDETTE, D. N, BRAIMAN, J, BROWNSCHEIDLE, C. M, COATS, M. E, COHAN, S. L, DOUGHERTY, D. S, JACOBS, L. D, KINKEL, R. P, MASS, M. K, MUNSCHAUER, F. E, PRIORE, R. L, PULLICINO, P. M, SCHEROKMAN, B. J, WEISTOCK-GUTTMAN, B, WHITHAM, R. H, COOKFAIR, D. L, HERNDON, R. M, RICHERT, J. R, SALAZAR, A. M, FISCHER, J. S, GRANGER, C. V, SIMON, J. H

Get full text

Thromboembolism prophylaxis in chronic atrial fibrillation : Practice patterns in community and tertiary-care hospitals by MUNSCHAUER, F. E, PRIORE, R. L, HENS, M, CASTILONE, A

“…By 1992, several prospective trials established the efficacy of anticoagulation (AC) and to some extent antiplatelet (AP) agents in the prevention of stroke in…”
Get full text

Assessment and management of neutralizing antibodies in patients with multiple sclerosis by Hartung, Hans-Peter, Munschauer, 3rd, Frederick E

“…The development of neutralizing antibodies (NAbs) to interferon beta (IFNbeta) products during treatment of MS poses a challenge for clinicians. Given the…”
Get full text

Managing side effects of interferon-beta in patients with relapsing-remitting multiple sclerosis by Munschauer, Frederick E., Kinkel, Revere Philip

“…In separate clinical trials, two preparations of recombinant interferon (IFN)-beta, IFN beta-1a and IFN beta-1b, reduced exacerbation rates in…”
Get full text

Abnormal respiration and sudden death during sleep in multiple system atrophy with autonomic failure by Munschauer, F E, Loh, L, Bannister, R, Newsom-Davis, J

“…We studied respiration during sleep in 7 patients with multiple system atrophy and autonomic failure (MSA-AF) and 7 control subjects. Although mean respiratory…”
Get full text